跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ASERIFLU 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS) - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ASERIFLU 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)
Approved
STANDARD
ASERIFLU 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)
Cipla Europe N.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 9, 2025
Approval ID
e5e56041ded26f67
Company
Cipla Europe N.V.
Type
Standard
Approval Details
Approval Id
e5e56041ded26f67
Drug Cima Aemps Name
ASERIFLU 50 MICROGRAMOS/250 MICROGRAMOS/INHALACION POLVO PARA INHALACION (UNIDOSIS)
Register Number
90008
Holder Company Name
Cipla Europe N.V.
Marketing Company Name
Cipla Europe N.V.
Authorization Date
2025-04-09
Dosage Form
POLVO PARA INHALACIÓN (UNIDOSIS)
Dose
50 microgramos/250 microgramos/dosis
Route Of Administration
VÍA INHALATORIA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Cipla Europe N.V.
Active Ingredients
SALMETEROL XINAFOATO
72,5 µg
FLUTICASONA PROPIONATO
250 µg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 9, 2025
Approval ID
e5e56041ded26f67
Type
Standard
Back to CIMA-AEMPS Approvals